Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2000, p. 612-616, Vol. 7, No. 4
Unité des Rickettsies, CNRS UPRESA
6020, Faculté de Médecine, Université de la
Mediterranée, 13385 Marseille Cedex 05, France,1 and Department of Virology,
Swedish Institute of Infectious Disease Control, S-105 21 Stockholm, Sweden2
Received 18 January 2000/Returned for modification 10 March
2000/Accepted 8 May 2000
Differentiation of murine typhus due to Rickettsia
typhi and epidemic typhus due to Rickettsia
prowazekii is critical epidemiologically but difficult
serologically. Using serological, epidemiological, and clinical
criteria, we selected sera from 264 patients with epidemic typhus and
from 44 patients with murine typhus among the 29,188 tested sera in our
bank. These sera cross-reacted extensively in indirect fluorescent
antibody assays (IFAs) against R. typhi and R. prowazekii, as 42% of the sera from patients with epidemic typhus and 34% of the sera from patients with murine typhus exhibited immunoglobulin M (IgM) and/or IgG titers against the homologous antigen
(R. prowazekii and R. typhi, respectively) that
were more than one dilution higher than those against the heterologous
antigen. Serum cross-adsorption studies and Western blotting were
performed on sera from 12 selected patients, 5 with murine typhus, 5 with epidemic typhus, and 2 suffering from typhus of undetermined
etiology. Differences in IFA titers against R. typhi and
R. prowazekii allowed the identification of the etiological
agent in 8 of 12 patients. Western blot studies enabled the
identification of the etiological agent in six patients. When the
results of IFA and Western blot studies were considered in combination,
identification of the etiological agent was possible for 10 of 12 patients. Serum cross-adsorption studies enabled the differentiation of
the etiological agent in all patients. Our study indicates that when
used together, Western blotting and IFA are useful serological tools to
differentiate between R. prowazekii and R. typhi exposures. While a cross-adsorption study is the definitive
technique to differentiate between infections with these agents, it was
necessary in only 2 of 12 cases (16.7%), and the high costs of such a
study limit its use.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Serological Differentiation of Murine Typhus and
Epidemic Typhus Using Cross-Adsorption and Western Blotting
*
Corresponding author. Mailing address: Unité des
Rickettsies, CNRS UPRESA 6020, Faculté de Médecine, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 05, France. Phone:
33.91.38.55.17. Fax: 33.91.83.03.90. E-mail:
Didier.Raoult{at}medecine.univ-mrs.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |